Literature DB >> 12710503

Vaginal immunity in the HSV-2 mouse model.

Margaret B Parr1, Earl L Parr.   

Abstract

Herpes simplex virus type 2 (HSV-2) is a sexually transmitted pathogen that infects the genital tract. Efforts to develop vaccines to protect women against this and other sexually transmitted pathogens would be facilitated by a better understanding of the immune mechanisms that protect the female reproductive tract against such infections. Such information would be invaluable in developing vaccine strategies to promote the type and magnitude of immune responses in the genital tract that would effectively protect against infection. This review focuses on recent studies using a progestin-treated adult mouse model to explore mucosal immunity to HSV-2 in the vagina. Evidence indicating a major role for both humoral and T cell immunity is presented.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12710503     DOI: 10.1080/08830180305228

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  25 in total

1.  Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles.

Authors:  Soumi Gupta; Ramesh Janani; Qian Bin; Paul Luciw; Catherine Greer; Silvia Perri; Harold Legg; John Donnelly; Susan Barnett; Derek O'Hagan; John M Polo; Michael Vajdy
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 2.  Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites.

Authors:  Olivia J Hall; Sabra L Klein
Journal:  Mucosal Immunol       Date:  2017-04-12       Impact factor: 7.313

3.  The cotton rat provides a novel model to study genital herpes infection and to evaluate preventive strategies.

Authors:  Kevin C Yim; Clifford J Carroll; Ana Tuyama; Natalia Cheshenko; Maria Josefina Carlucci; David D Porter; Gregory A Prince; Betsy C Herold
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue.

Authors:  Norifumi Iijima; Lisa M Mattei; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

5.  Vaginal memory T cells induced by intranasal vaccination are critical for protective T cell recruitment and prevention of genital HSV-2 disease.

Authors:  Ayuko Sato; Aldina Suwanto; Manami Okabe; Shintaro Sato; Tomonori Nochi; Takahiko Imai; Naoto Koyanagi; Jun Kunisawa; Yasushi Kawaguchi; Hiroshi Kiyono
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

6.  Estradiol improves genital herpes vaccine efficacy in mice.

Authors:  Jeffry W Pennock; Rachael Stegall; Brent Bell; Gracie Vargas; Massoud Motamedi; Gregg Milligan; Nigel Bourne
Journal:  Vaccine       Date:  2009-08-04       Impact factor: 3.641

7.  An intranasal heat shock protein based vaccination strategy confers protection against mucosal challenge with herpes simplex virus.

Authors:  Christopher D Pack; Malgorzata Gierynska; Barry T Rouse
Journal:  Hum Vaccin       Date:  2008-09-28

8.  Intraepithelial gammadelta T cells may bridge a gap between innate immunity and acquired immunity to herpes simplex virus type 2.

Authors:  Hitoshi Nishimura; Toshiki Yajima; Yoshiko Kagimoto; Mutsuhiro Ohata; Taketo Watase; Kenji Kishihara; Fumi Goshima; Yukihiro Nishiyama; Yasunobu Yoshikai
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  HSV type 2 infection increases HIV DNA detection in vaginal tissue of mice expressing human CD4 and CCR5.

Authors:  M Reza Zariffard; Mohammed Saifuddin; Alison Finnegan; Gregory T Spear
Journal:  AIDS Res Hum Retroviruses       Date:  2009-11       Impact factor: 2.205

10.  Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection.

Authors:  Nicolas Cuburu; Mi-Na Kweon; Catherine Hervouet; Hye-Ran Cha; Yuk-Ying S Pang; Jan Holmgren; Konrad Stadler; John T Schiller; Fabienne Anjuère; Cecil Czerkinsky
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.